|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| Net cash used in operating activities | |
| Cash Flows from Investing Activities | |
| Purchase of property and equipment | |
| Proceeds from short-term deposits | |
| Interest received | |
| Net cash provided by investing activities, net | |
| Cash Flows from Financing Activities | |
| Exercise of options | |
| Payment to the Israel Innovation Authority | |
| Receipt of grants from Israel Innovation Authority | |
| Principal portion of lease payments | |
| Interest portion of lease payments | |
| Net cash provided by (used in) financing activities | |
| Increase (decrease) in cash and cash equivalents | |
| Cash and cash equivalents at beginning of the year | |
| Exchange differences on cash and cash equivalents | |
| Cash and cash equivalents at end of the year | |
| Net loss | |
| Adjustments for: | |
| Depreciation and amortization | |
| Share-based compensation | |
| Financial expenses (income) | |
| Exchange differences | |
| Adjustments for profit loss | |
| Decrease (increase) in trade receivables | |
| Decrease (increase) in other receivables | |
| Decrease (increase) in inventory | |
| Decrease in trade payables | |
| Increase (decrease) in other payables and accruals | |
| Increase (decrease) in contract liabilities | |
| Increase in liability of share-based compensation | |
| Changes in operating asset and liability items, net | |
| Supplemental information on non-cash transactions: | |
| Changes in right-of-use asset and lease liabilities |
Loading...
